rs121917945
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM2PM5PP2PP3_ModeratePP5_Very_Strong
The NM_001165963.4(SCN1A):c.4352C>T(p.Pro1451Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P1451T) has been classified as Pathogenic.
Frequency
Consequence
NM_001165963.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SCN1A | NM_001165963.4 | c.4352C>T | p.Pro1451Leu | missense_variant | Exon 26 of 29 | ENST00000674923.1 | NP_001159435.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SCN1A | ENST00000674923.1 | c.4352C>T | p.Pro1451Leu | missense_variant | Exon 26 of 29 | NM_001165963.4 | ENSP00000501589.1 | |||
| SCN1A | ENST00000303395.9 | c.4352C>T | p.Pro1451Leu | missense_variant | Exon 25 of 28 | 5 | ENSP00000303540.4 | |||
| SCN1A | ENST00000375405.7 | c.4319C>T | p.Pro1440Leu | missense_variant | Exon 23 of 26 | 5 | ENSP00000364554.3 | |||
| SCN1A | ENST00000409050.2 | c.4268C>T | p.Pro1423Leu | missense_variant | Exon 25 of 28 | 5 | ENSP00000386312.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1453276Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 723084
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Severe myoclonic epilepsy in infancy Pathogenic:1Other:1
Developmental and epileptic encephalopathy Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Pro1451 amino acid residue in SCN1A. Other variant(s) that disrupt this residue have been observed in affected individuals (PMID: 21248271, 26096185), suggesting that it is a clinically significant residue. As a result, variants that disrupt this residue are likely to be causative of disease. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has been observed to be de novo in an individual affected with severe myoclonic epilepsy in infancy (SMEI) also known as Dravet syndrome (PMID: 17054684). ClinVar contains an entry for this variant (Variation ID: 68544). This variant is not present in population databases (ExAC no frequency). This sequence change replaces proline with leucine at codon 1451 of the SCN1A protein (p.Pro1451Leu). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and leucine.
See cases Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at